Paper

Integrated Assessment of Phase 2 Data on GalNAc 3 -Conjugated 2′- O -Methoxyethyl-Modified Antisense Oligonucleotides

Nucleic Acid Therapeutics · 2022 · Brenda F Baker, Shuting Xia, Wesley Partridge et al.